Thursday, December 19, 2013
PORTLAND, Ore. (Dec. 19, 2013)—According to the new market research report titled "Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) - Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts, 2012 - 2020" by Allied Market Research, the global continuous glucose monitoring (CGM) market is projected to reach $568.5 million by 2020 from 2012 value of $194.8 million growing at a CAGR of 14.8 percent during 2013 - 2020.
The major factors driving the market growth are convenience offered by CGM over conventional glucose monitoring devices, earlier detection of the hypo and hyperglycemic events, rise in incidences of diabetes cases globally, and awareness among global population.
"The market is overcoming several challenges toward the commercialization of closed loop CGMs with significant focus on technological innovation. This is expected to take the concept of CGM to a next level from research to mass adoption" noted AMR analyst Debbie Shields. Despite such encouraging innovations, commercialization has not reached to desired levels. Major factors responsible for this are issues related with accuracy as well as cost, less attractive reimbursement coverage, and strict regulatory impositions. "However, the under commercialization is presenting opportunities for the marketers as new and innovative products will easily take the advantage of lower product presence" Debbie explains. The impact of FDA approval for artificial pancreas, superiority of CGMs over self-monitoring devices and rise in diabetes cases will have significant impact on the overall market growth.
Click here to read the complete report.
